tradingkey.logo

electroCore, Inc.

ECOR
5.450USD
+0.380+7.50%
終値 02/06, 16:00ET15分遅れの株価
41.61M時価総額
損失額直近12ヶ月PER

electroCore, Inc.

5.450
+0.380+7.50%

詳細情報 electroCore, Inc. 企業名

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

electroCore, Inc.の企業情報

企業コードECOR
会社名electroCore, Inc.
上場日Jun 22, 2018
最高経営責任者「CEO」Goldberger (Daniel S)
従業員数73
証券種類Ordinary Share
決算期末Jun 22
本社所在地200 Forge Way
都市ROCKAWAY
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号07866
電話番号19732900097
ウェブサイトhttps://www.electrocore.com/
企業コードECOR
上場日Jun 22, 2018
最高経営責任者「CEO」Goldberger (Daniel S)

electroCore, Inc.の経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Julie A. Goldstein
Ms. Julie A. Goldstein
Independent Director
Independent Director
--
--
Mr. Joshua S. Lev
Mr. Joshua S. Lev
Chief Financial Officer
Chief Financial Officer
--
--
Mr. James C. Theofilos
Mr. James C. Theofilos
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%
地域別USD
会社名
収益
比率
United States
8.22M
94.63%
United Kingdom
402.00K
4.63%
Other
48.00K
0.55%
Japan
17.00K
0.20%
事業別
地域別
事業別USD
会社名
収益
比率
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%

株主

更新時刻: Fri, Feb 6
更新時刻: Fri, Feb 6
株主統計
種類
株主統計
株主統計
比率
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
他の
72.98%
株主統計
株主統計
比率
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
他の
72.98%
種類
株主統計
比率
Individual Investor
27.86%
Corporation
8.76%
Investment Advisor
7.46%
Investment Advisor/Hedge Fund
1.59%
Hedge Fund
1.57%
Research Firm
0.02%
他の
52.74%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
75
727.72K
16.70%
--
2025Q3
75
727.72K
17.61%
-444.98K
2025Q2
70
1.17M
19.50%
-199.13K
2025Q1
65
1.37M
13.77%
+380.78K
2024Q4
69
936.59K
18.00%
-138.83K
2024Q3
59
1.06M
17.69%
+20.62K
2024Q2
62
1.04M
19.14%
+51.56K
2024Q1
68
992.08K
19.07%
-152.78K
2023Q4
66
961.96K
18.72%
+22.04K
2023Q3
73
937.71K
13.66%
+316.94K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Zhang (Tianyi)
734.64K
9.19%
+734.64K
--
May 15, 2025
Theofilos (Charles Steve)
444.53K
5.56%
--
--
Jul 04, 2025
Hilve Holdings Ltd
432.00K
5.4%
+432.00K
--
Aug 15, 2025
Errico (Thomas J.)
306.38K
3.83%
+26.61K
+9.51%
Sep 02, 2025
The Vanguard Group, Inc.
233.47K
2.92%
+1.14K
+0.49%
Sep 30, 2025
Goldberger (Daniel S)
185.90K
2.32%
+1.00K
+0.54%
Dec 02, 2025
Happy Holstein Management, LLC
153.17K
1.92%
--
--
Jul 04, 2025
MAZ Partners, L.P.
115.52K
1.44%
-156.44K
-57.52%
May 13, 2025
Patton (Thomas M)
102.78K
1.29%
+19.01K
+22.69%
Sep 02, 2025
Goldstein (Julie Ann)
101.39K
1.27%
+19.01K
+23.08%
Sep 02, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
日付
配当落ち日
種類
比率
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
KeyAI